بدائل البحث:
larger decrease » marked decrease (توسيع البحث)
lower decrease » linear decrease (توسيع البحث), we decrease (توسيع البحث), showed decreased (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
lower decrease » linear decrease (توسيع البحث), we decrease (توسيع البحث), showed decreased (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
-
201
-
202
-
203
-
204
-
205
-
206
-
207
Comparison of renal tissue pathological damage grades across different groups at all time points.
منشور في 2024الموضوعات: -
208
Comparison of PCNA expression grades across different groups at various time points.
منشور في 2024الموضوعات: -
209
PAS staining images of pathological changes in renal tissues among 4 groups (×400).
منشور في 2024الموضوعات: -
210
-
211
-
212
Comparison of mTOR expression grading among different groups at different time points.
منشور في 2024الموضوعات: -
213
-
214
Downregulation of <i>TcPiezo1</i> expression decreases Ca<sup>2+</sup> entry in <i>T. cruzi.</i>
منشور في 2025"…(B) Downregulation of <i>TcPiezo1</i> expression showed a significant decrease of intracellular Ca<sup>2+</sup> (+Tet). …"
-
215
-
216
-
217
Flowchart of the screening process.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
218
Result of the AMSTAR-2 assessments.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
219
Characteristics of included reviews.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"
-
220
Result of the PRISMA assessments.
منشور في 2025"…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…"